sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [Epclusa]

RxCUI: 1799218
RxNorm name: sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [Epclusa]
Display name: sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [Epclusa]
Full name: sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [Epclusa]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Epclusa	VELPATASVIR AND SOFOSBUVIR	Gilead Sciences, Inc.	7f30631a-ee3b-4cfe-866b-964df3f0a44f	2024-06-05	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1799218

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
7f30631a-ee3b-4cfe-866b-964df3f0a44f	Epclusa 400 MG / 100 MG Oral Tablet [PSN] · sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [Epclusa] [SBD] · Epclusa (sofosbuvir 400 MG / velpatasvir 100 MG) Oral Tablet [SY]	3	14	These highlights do not include all the information needed to use EPCLUSA safely and effectively. See full prescribing information for EPCLUSA. EPCLUSA ® (sofosbuvir and velpatasvir) tablets, for oral use EPCLUSA ® (sofosbuvir and velpatasvir) oral pellets Initial U.S. Approval: 2016	20240605
996466df-f236-4804-b10f-838aa83231a1	Epclusa 400 MG / 100 MG Oral Tablet [PSN] · sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [Epclusa] [SBD] · Epclusa (sofosbuvir 400 MG / velpatasvir 100 MG) Oral Tablet [SY]	3	6	These highlights do not include all the information needed to use EPCLUSA safely and effectively. See full prescribing information for EPCLUSA. EPCLUSA™ (sofosbuvir and velpatasvir) tablets, for oral use Initial U.S. Approval: 2016 GILEAD ACCESS PROGRAM	20250424